157 related articles for article (PubMed ID: 38575744)
21. Progressive neurocognitive impairment in young adult survivors of childhood acute lymphoblastic leukemia.
Harila MJ; Winqvist S; Lanning M; Bloigu R; Harila-Saari AH
Pediatr Blood Cancer; 2009 Aug; 53(2):156-61. PubMed ID: 19405135
[TBL] [Abstract][Full Text] [Related]
22. Neuropsychological outcome in chemotherapy-only-treated children with acute lymphoblastic leukemia.
Jansen NC; Kingma A; Schuitema A; Bouma A; Veerman AJ; Kamps WA
J Clin Oncol; 2008 Jun; 26(18):3025-30. PubMed ID: 18565888
[TBL] [Abstract][Full Text] [Related]
23. Everyday executive function in standard-risk acute lymphoblastic leukemia survivors.
Walsh KS; Paltin I; Gioia GA; Isquith P; Kadan-Lottick NS; Neglia JP; Brouwers P
Child Neuropsychol; 2015; 21(1):78-89. PubMed ID: 24428397
[TBL] [Abstract][Full Text] [Related]
24. Executive function late effects in survivors of pediatric brain tumors and acute lymphoblastic leukemia.
Winter AL; Conklin HM; Tyc VL; Stancel H; Hinds PS; Hudson MM; Kahalley LS
J Clin Exp Neuropsychol; 2014; 36(8):818-30. PubMed ID: 25126830
[TBL] [Abstract][Full Text] [Related]
25. Association between obesity and neurocognitive function in survivors of childhood acute lymphoblastic leukemia treated only with chemotherapy.
Iijima M; Liu W; Panetta JC; Hudson MM; Pui CH; Srivastava DK; Krull KR; Inaba H
Cancer; 2021 Sep; 127(17):3202-3213. PubMed ID: 33914910
[TBL] [Abstract][Full Text] [Related]
26. A cross-sectional follow-up study of physical morbidities, neurocognitive function, and attention problems in post-treatment childhood acute lymphoblastic leukemia survivors.
Chiou SS; Lin PC; Liao YM; Yang P
Kaohsiung J Med Sci; 2019 Jun; 35(6):373-378. PubMed ID: 30913362
[TBL] [Abstract][Full Text] [Related]
27. Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola LM; Krull KR; Pui CH; Pei D; Cheng C; Reddick WE; Conklin HM
J Clin Oncol; 2016 Apr; 34(11):1239-47. PubMed ID: 26858334
[TBL] [Abstract][Full Text] [Related]
28. Brain Network Connectivity and Executive Function in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
Kesler SR; Ogg R; Reddick WE; Phillips N; Scoggins M; Glass JO; Cheung YT; Pui CH; Robison LL; Hudson MM; Krull KR
Brain Connect; 2018 Aug; 8(6):333-342. PubMed ID: 29936880
[TBL] [Abstract][Full Text] [Related]
29. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity.
Buizer AI; de Sonneville LM; van den Heuvel-Eibrink MM; Veerman AJ
Pediatr Blood Cancer; 2005 Sep; 45(3):281-90. PubMed ID: 15806539
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia.
Peterson CC; Johnson CE; Ramirez LY; Huestis S; Pai AL; Demaree HA; Drotar D
Pediatr Blood Cancer; 2008 Jul; 51(1):99-104. PubMed ID: 18322925
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy Pharmacodynamics and Neuroimaging and Neurocognitive Outcomes in Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia.
Krull KR; Cheung YT; Liu W; Fellah S; Reddick WE; Brinkman TM; Kimberg C; Ogg R; Srivastava D; Pui CH; Robison LL; Hudson MM
J Clin Oncol; 2016 Aug; 34(22):2644-53. PubMed ID: 27269941
[TBL] [Abstract][Full Text] [Related]
32. The effect of cardiorespiratory fitness and physical activity levels on cognitive functions in survivors of childhood acute lymphoblastic leukemia.
Gendron É; Caru M; Léveillé P; Sultan S; Robaey P; Lemay V; Drouin S; Bertout L; Andelfinger G; Krajinovic M; Laverdière C; Sinnett D; Lippé S; Curnier D
Pediatr Hematol Oncol; 2020 Oct; 37(7):582-598. PubMed ID: 32510265
[No Abstract] [Full Text] [Related]
33. Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood brain tumor.
McCurdy MD; Rane S; Daly BP; Jacobson LA
J Neurooncol; 2016 Mar; 127(1):137-44. PubMed ID: 26725098
[TBL] [Abstract][Full Text] [Related]
34. The usefulness of growth hormone treatment for psychological status in young adult survivors of childhood leukaemia: an open-label study.
Huisman J; Aukema EJ; Deijen JB; van Coeverden SC; Kaspers GJ; van der Pal HJ; Delemarre-van de Waal HA
BMC Pediatr; 2008 Jun; 8():25. PubMed ID: 18570650
[TBL] [Abstract][Full Text] [Related]
35. Visual Attention and Math Performance in Survivors of Childhood Acute Lymphoblastic Leukemia.
Richard AE; Hodges EK; Heinrich KP
Arch Clin Neuropsychol; 2018 Dec; 33(8):1015-1023. PubMed ID: 29373636
[TBL] [Abstract][Full Text] [Related]
36. The contribution of neurocognitive functioning to quality of life after childhood acute lymphoblastic leukemia.
Kunin-Batson A; Kadan-Lottick N; Neglia JP
Psychooncology; 2014 Jun; 23(6):692-9. PubMed ID: 24497266
[TBL] [Abstract][Full Text] [Related]
37. Computerized Cognitive Training for Amelioration of Cognitive Late Effects Among Childhood Cancer Survivors: A Randomized Controlled Trial.
Conklin HM; Ogg RJ; Ashford JM; Scoggins MA; Zou P; Clark KN; Martin-Elbahesh K; Hardy KK; Merchant TE; Jeha S; Huang L; Zhang H
J Clin Oncol; 2015 Nov; 33(33):3894-902. PubMed ID: 26460306
[TBL] [Abstract][Full Text] [Related]
38. Interactions between visual working memory and visual attention among survivors of pediatric acute lymphoblastic leukemia (ALL) and their healthy peers.
Treviño M; Breitmeyer BG; Ris MD; Fletcher JM; Kamdar K; Okcu MF; Parke EM; Raghubar KP
J Clin Exp Neuropsychol; 2019 Nov; 41(9):974-986. PubMed ID: 31327287
[No Abstract] [Full Text] [Related]
39. The Behavior Rating Inventory of Executive Function (BRIEF) to Identify Pediatric Acute Lymphoblastic Leukemia (ALL) Survivors At Risk for Neurocognitive Impairment.
Viola A; Balsamo L; Neglia JP; Brouwers P; Ma X; Kadan-Lottick NS
J Pediatr Hematol Oncol; 2017 Apr; 39(3):174-178. PubMed ID: 28085741
[TBL] [Abstract][Full Text] [Related]
40. Association between fatigue and sleep disturbances during treatment for pediatric acute lymphoblastic leukemia and posttreatment neurocognitive performance.
Vasquez P; Escalante J; Raghubar KP; Kahalley LS; Taylor OA; Moore IK; Hockenberry MJ; Scheurer ME; Brown AL
Pediatr Blood Cancer; 2022 May; 69(5):e29507. PubMed ID: 34889514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
